0001209191-16-136483.txt : 20160811 0001209191-16-136483.hdr.sgml : 20160811 20160811084437 ACCESSION NUMBER: 0001209191-16-136483 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160809 FILED AS OF DATE: 20160811 DATE AS OF CHANGE: 20160811 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC CENTRAL INDEX KEY: 0001158895 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 781-221-2266 MAIL ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jasinski Lawrence J CENTRAL INDEX KEY: 0001366346 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33092 FILM NUMBER: 161823113 MAIL ADDRESS: STREET 1: SOTEIRA INC. STREET 2: 14 TECH CIRCLE CITY: NATICK STATE: MA ZIP: 01760 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-08-09 0 0001158895 LEMAITRE VASCULAR INC LMAT 0001366346 Jasinski Lawrence J C/O LEMAITRE VASCULAR, INC. 63 SECOND AVENUE BURLINGTON MA 01803 1 0 0 0 Common Stock 2016-08-09 4 M 0 2500 6.67 A 12863 D Common Stock 2016-08-09 4 M 0 2500 7.87 A 15363 D Common Stock 2016-08-09 4 M 0 2500 11.43 A 17863 D Common Stock 2016-08-09 4 S 0 7500 17.6001 D 10363 D Stock Option (Right to Buy) 6.67 2016-08-09 4 M 0 2500 0.00 D 2013-07-24 2018-07-24 Common Stock 2500 0 D Stock Option (Right to Buy) 7.87 2016-08-09 4 M 0 2500 0.00 D 2014-07-24 2019-07-24 Common Stock 2500 2500 D Stock Option (Right to Buy) 11.43 2016-08-09 4 M 0 2500 0.00 D 2015-07-23 2020-07-23 Common Stock 2500 5000 D Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $17.50 to $17.81. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining two years. /s/ Laurie Churchill, Attorney-in-fact 2016-08-11